Showing 31 - 40 of 114
Eager for high season
Business, Dusida Worrachaddejchai, Published on 09/10/2021
» Tourism operators in sandbox areas are upbeat about the outlook for the high season after Thailand was removed from the UK's red list for travel, effective Oct 11.
Australia to End Travel Ban in Pivot to Living With Covid-19
Business, Published on 02/10/2021
» Australia plans to start reopening its international border in November, ending one of the world's strictest pandemic-era travel bans as authorities pivot from trying to suppress Covid-19 to living with it.
Pfizer Thailand delivers breakthrough results amid the pandemic
Business, Published on 28/09/2021
» There has never been a time when the US drugmaker and vaccine manufacturer Pfizer's purpose of "breakthroughs that change patients' lives" has been more fitting than in the midst of the Covid-19 pandemic.
Phuket sours on Sandbox
News, Achadthaya Chuenniran, Published on 06/09/2021
» The private sector in Phuket is urging the government to fully reopen the resort island by Dec 1, saying the move can bring in more than 210 billion baht in tourism-related revenue in just three months.
Shares steady ahead of key speech by Fed chief
Business, Published on 28/08/2021
» Recap: Global shares steadied near record highs yesterday as investors awaited a much-anticipated speech by Federal Reserve Chairman Jerome Powell that might shed light on when and how the Fed intends to start scaling back its economic stimulus.
To encourage vaccinations, more US firms turn to incentives -- and threats
AFP, Published on 27/08/2021
» NEW YORK: In the wake of full US approval for the Pfizer/BioNTech anti-Covid vaccine this week, more and more American companies are looking at mandatory vaccinations for employees -- and customers.
As Covid-19 Boosters Loom, Pfizer and Moderna Expect to See Billions More in Sales
Business, Published on 21/08/2021
» Vaccine makers Pfizer Inc. and Moderna Inc. are on track to notch billions more in sales than previously expected, as new booster-shot strategies and concerns about the Delta variant push demand, and the companies raise prices in the U.S. and elsewhere.
Journeys of discovery
Asia focus, Nareerat Wiriyapong, Published on 16/08/2021
» Sipping green tea after having a Thai lunch at his house, Farid Bidgoli looks relaxed yet energetic, and ready for an interview. From his appearance and accent, the 42-year-old executive looks exactly like someone from the UK where he was born, though he is half Iranian with a spirit inherited from his father.
AstraZeneca Loses Money on Covid-19 Vaccine for Second Straight Quarter
Business, Published on 07/08/2021
» AstraZeneca PLC narrowed losses from its Covid-19 vaccine in the second quarter but its earnings fell below forecast, highlighting the divide between it and rivals, such as Pfizer Inc., that are profiting from their shots.
SEC probes THG vaccine mystery
Business, Nuntawun Polkuamdee, Published on 05/08/2021
» The Securities and Exchange Commission (SEC) on Wednesday ordered Thonburi Healthcare Group (THG) and its chairman Boon Vanasin to clarify certain facts within seven days regarding his recently scrapped plans to import Pfizer Covid-19 vaccines into Thailand.